Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORRECT: Endo-HDR vs Chemoradiation for Rectal Cancer
NCT02017704Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jun 2014
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoint: Pathologic Complete Response up to 60 months. Started Jun 2014; status: completed.
Beyond the preview
Go deeper on NCT02017704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02017704.